(Q34105463)

31 July 2017

1 reference

title

Steroids or vigabatrin in the treatment of infantile spasms? (English)

1 reference

31 July 2017

Riikonen RS

1

1 reference

31 July 2017

publication date

1 November 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

23

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

403-408

1 reference

Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Vigabatrin as a first-line drug in West syndrome: clinical and electroencephalographic outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

ACTH versus vigabatrin therapy in infantile spasms: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Vigabatrin in the treatment of infantile spasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Tuberous sclerosis and infantile spasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

ACTH therapy in infantile spasms: side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

A Long-term Follow-up Study of 214 Children with the Syndrome of Infantile Spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Double-blind study of ACTH vs prednisone therapy in infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Co-trimoxazole for prevention of infection in acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Cardiac hypertrophy secondary to ACTH treatment in children

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Adrenocortical hyporesponsiveness after treatment with ACTH of infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Hypothalamo-pituitary-adrenal function in infantile spasms: effects of ACTH therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

West syndrome: individualized ACTH therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Visual function loss from vigabatrin: effect of stopping the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Outer retinal dysfunction in patients treated with vigabatrin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Visual field constriction in children treated with vigabatrin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

Visual field constriction is not limited to children treated with vigabatrin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900218-6

7 January 2021

10.1016/S0887-8994(00)00218-6

Identifiers

DOI

1 reference

31 July 2017

1 reference